Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Up 1.2% – Still a Buy?

Posted by Paula Ricardo on May 27th, 2026

Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) shot up 1.2% during trading on Tuesday . The stock traded as high as $30.74 and last traded at $30.72. 7,201 shares were traded during mid-day trading, an increase of 38% from the average session volume of 5,222 shares. The stock had previously closed at $30.36.

Analyst Ratings Changes

Several brokerages have recently commented on CZMWY. Sanford C. Bernstein lowered shares of Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. Zacks Research upgraded shares of Carl Zeiss Meditec to a “hold” rating in a report on Friday, April 24th. One investment analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Carl Zeiss Meditec presently has a consensus rating of “Hold”.

View Our Latest Stock Analysis on Carl Zeiss Meditec

Carl Zeiss Meditec Trading Up 1.2%

The stock’s fifty day simple moving average is $29.83 and its 200-day simple moving average is $37.46.

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.